# Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food

> **NCT00868907** · PHASE1 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 101 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 35 mg risedronate DR tablet
- **DRUG:** 35 mg risedronate DR tablet
- **DRUG:** 35 mg risedronate DR tablet

## Key facts

- **NCT ID:** NCT00868907
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2011-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868907, "Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00868907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*